Skip to main content
Premium Trial:

Request an Annual Quote

Could Mix It Up

The US Food and Drug Administration is developing a plan that would allow people to receive a SARS-CoV-2 vaccine booster that differs from the initial vaccine they received, according to the New York Times.

This mix-and-match approach, it says, would give vaccine providers more flexibility, but could also reduce the demand for a Johnson & Johnson vaccine. Last week, a study posted to MedRxiv reported that boosters from Pfizer-BioNTech, Moderna, and J&J all provided an increased immune response to SARS-CoV-2, but that people who initially received the J&J vaccine saw a higher response when given a mRNA-based booster. FDA has already authorized a Pfizer-BioNTech booster for people 65 or older and younger at-risk individuals and is currently weighing boosters for the Moderna and J&J vaccines, a decision on which the Times says is expected by late Wednesday.

Some officials tell the Times that having more booster options could make it easier to administer boosters, though others say that the various options and recommendations — boosters are expected to be authorized for all J&J vaccine recipients 18 years old and older, while the authorization for Moderna recipients is expected to be for those 65 years old or older or younger but at high-risk, like the Pfizer-BioNTech vaccine — could lead to confusion.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.